• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

28例垂体腺瘤中的单核细胞浸润及HLA-Dr表达

Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas.

作者信息

Rossi M L, Jones N R, Esiri M M, Havas L, al Izzi M, Coakham H B

机构信息

Dept of Neuropathology, Radcliffe Infirmary, Oxford, U.K.

出版信息

Tumori. 1990 Dec 31;76(6):543-7. doi: 10.1177/030089169007600605.

DOI:10.1177/030089169007600605
PMID:2284689
Abstract

Frozen sections from 28 pituitary adenomas were reached with a panel of monoclonal antibodies to macrophages, lymphocytes and HLA-Dr invariant chain. A low number of macrophages were demonstrated in all tumors, mainly perivascular. CD8 and CD4 lymphocytes were detected in even smaller numbers in 80% and 14% of tumors respectively. B lymphocytes were present in only 1 case. An occasional NK cell was present in 1/13 cases studied. HLA-Dr antigen was expressed by macrophages in all cases and by tumor cells in 2 growth hormone-producing adenomas/19 adenomas. These findings may represent evidence for a low degree of cellular immune response to pituitary adenomas.

摘要

用一组针对巨噬细胞、淋巴细胞和HLA - Dr恒定链的单克隆抗体对28例垂体腺瘤的冰冻切片进行检测。在所有肿瘤中均发现少量巨噬细胞,主要位于血管周围。分别在80%和14%的肿瘤中检测到数量更少的CD8和CD4淋巴细胞。仅在1例中发现B淋巴细胞。在所研究的13例中有1例偶尔出现自然杀伤细胞。在所有病例中巨噬细胞均表达HLA - Dr抗原,在19例腺瘤中有2例生长激素分泌型腺瘤的肿瘤细胞也表达该抗原。这些发现可能表明对垂体腺瘤存在低度的细胞免疫反应。

相似文献

1
Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas.28例垂体腺瘤中的单核细胞浸润及HLA-Dr表达
Tumori. 1990 Dec 31;76(6):543-7. doi: 10.1177/030089169007600605.
2
Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.HLA-DR、HLA-DP、HLA-DQ及相关恒定链(Ii)在正常结直肠黏膜、腺瘤及癌组织中的差异表达
Virchows Arch A Pathol Anat Histopathol. 1988;412(4):315-22. doi: 10.1007/BF00750257.
3
Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.垂体腺瘤中的免疫细胞浸润:较大腺瘤中巨噬细胞更多,生长激素腺瘤中T细胞更多。
Endocr Pathol. 2015 Sep;26(3):263-72. doi: 10.1007/s12022-015-9383-6.
4
Mononuclear cell infiltrate and HLA-Dr expression in intra- and extradural secondary carcinomas.硬膜内和硬膜外继发性癌中的单核细胞浸润及HLA-Dr表达
Pathol Res Pract. 1991 Jan;187(1):55-61. doi: 10.1016/s0344-0338(11)81045-9.
5
Mononuclear cell infiltrate, HLA-Dr expression and proliferation in 37 acoustic schwannomas.37例听神经瘤中的单核细胞浸润、HLA-Dr表达及增殖情况
Histol Histopathol. 1990 Oct;5(4):427-32.
6
Characterization of the mononuclear cell infiltrate and HLA-Dr expression in 19 oligodendrogliomas.19例少突胶质细胞瘤中单核细胞浸润及HLA-Dr表达的特征分析
Surg Neurol. 1991 Aug;36(2):119-25. doi: 10.1016/0090-3019(91)90229-3.
7
Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas.全面分析垂体腺瘤的免疫图谱:免疫治疗对垂体腺瘤的影响。
J Neurooncol. 2020 Sep;149(3):473-487. doi: 10.1007/s11060-020-03636-z. Epub 2020 Oct 9.
8
Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon.结肠正常黏膜、管状绒毛状腺瘤及浸润性癌中HLA-DR抗原的表达及淋巴细胞浸润特征
Chirurgia (Bucur). 2005 Sep-Oct;100(5):451-6.
9
Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.肾细胞癌中HLA-II类抗原和肿瘤浸润单核细胞的免疫组织化学分析:与临床和组织病理学数据的相关性
Neoplasma. 1999;46(3):173-8.
10
Folliculo-stellate cells of human pituitary adenomas: immunohistochemical study of the monocyte/macrophage phenotype expression.人垂体腺瘤的滤泡星状细胞:单核细胞/巨噬细胞表型表达的免疫组织化学研究
Neuroendocrinology. 1997 Jan;65(1):47-52. doi: 10.1159/000127163.

引用本文的文献

1
A Nexus of Biomolecular Complexities in Pituitary Neuroendocrine Tumors: Insights into Key Molecular Drivers.垂体神经内分泌肿瘤中生物分子复杂性的关联:对关键分子驱动因素的见解
Biomedicines. 2025 Apr 16;13(4):968. doi: 10.3390/biomedicines13040968.
2
Tumour microenvironment and pituitary tumour behaviour.肿瘤微环境与垂体肿瘤行为
J Endocrinol Invest. 2023 Jun;46(6):1047-1063. doi: 10.1007/s40618-023-02089-1. Epub 2023 Apr 15.
3
Alterations in CD8 Tregs, CD56 Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs).
CD8+T 调节性 T 细胞、CD56 自然杀伤细胞和 IL-10 的改变与无功能垂体腺瘤 (NFPAs) 的侵袭性有关。
Pathol Oncol Res. 2021 Mar 25;27:598887. doi: 10.3389/pore.2021.598887. eCollection 2021.
4
Research advances on the immune research and prospect of immunotherapy in pituitary adenomas.垂体腺瘤免疫研究进展及免疫治疗前景
World J Surg Oncol. 2021 Jun 5;19(1):162. doi: 10.1186/s12957-021-02272-9.
5
Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17.乳酸诱导的肿瘤相关巨噬细胞M2极化通过分泌CCL17促进垂体腺瘤的侵袭。
Theranostics. 2021 Feb 6;11(8):3839-3852. doi: 10.7150/thno.53749. eCollection 2021.
6
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.免疫治疗在难治性垂体腺瘤和垂体癌中的进展。
Front Endocrinol (Lausanne). 2020 Dec 11;11:608422. doi: 10.3389/fendo.2020.608422. eCollection 2020.
7
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.趋化因子调节垂体神经内分泌肿瘤的肿瘤微环境。
Acta Neuropathol Commun. 2019 Nov 8;7(1):172. doi: 10.1186/s40478-019-0830-3.
8
The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.垂体肿瘤的微环境——生物学及治疗意义
Cancers (Basel). 2019 Oct 21;11(10):1605. doi: 10.3390/cancers11101605.
9
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.人类垂体肿瘤中程序性死亡配体1(PD-L1)表达增加。
Oncotarget. 2016 Nov 22;7(47):76565-76576. doi: 10.18632/oncotarget.12088.
10
Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.垂体腺瘤中的免疫细胞浸润:较大腺瘤中巨噬细胞更多,生长激素腺瘤中T细胞更多。
Endocr Pathol. 2015 Sep;26(3):263-72. doi: 10.1007/s12022-015-9383-6.